酮咯酸
医学
围手术期
麻醉
止痛药
疼痛管理
术后疼痛
外科
作者
Benjamin Maslin,Lawrence Lipana,Brandon Roth,Gopal Kodumudi,Nalini Vadivelu
出处
期刊:Current Drug Safety
[Bentham Science]
日期:2017-02-09
卷期号:12 (1): 67-73
被引量:25
标识
DOI:10.2174/1574886311666160719154420
摘要
Background: Ketorolac use has significantly expanded for postoperative pain management since it first became available in the United States, primarily due to well established effects on patient pain scores and its ability to reduce perioperative opioid requirements. As an inhibitor of cyclooxygenase, ketorolac use has raised clinical concern including particular controversy regarding its potential effects on bone healing, postoperative kidney function and perioperative bleeding. Keywords: Ketorolac, postoperative pain, toradol, non-steroid anti-inflammatory drug.
科研通智能强力驱动
Strongly Powered by AbleSci AI